These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6507037)

  • 1. Epidemiology of myasthenia gravis in Norway.
    Storm-Mathisen A
    Acta Neurol Scand; 1984 Oct; 70(4):274-84. PubMed ID: 6507037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Juvenile myasthenia gravis in Norway: A nationwide epidemiological study.
    Popperud TH; Boldingh MI; Brunborg C; Faiz KW; Heldal AT; Maniaol AH; Müller KI; Rasmussen M; Øymar K; Kerty E
    Eur J Paediatr Neurol; 2017 Mar; 21(2):312-317. PubMed ID: 27666466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A national epidemiological study of Myasthenia Gravis in Australia.
    Gattellari M; Goumas C; Worthington JM
    Eur J Neurol; 2012 Nov; 19(11):1413-20. PubMed ID: 22469211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of myasthenia gravis in the province of Trento (northern Italy).
    Ferrari G; Lovaste MG
    Neuroepidemiology; 1992; 11(3):135-42. PubMed ID: 1407249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality and survival in myasthenia gravis: a Danish population based study.
    Christensen PB; Jensen TS; Tsiropoulos I; Sørensen T; Kjaer M; Højer-Pedersen E; Rasmussen MJ; Lehfeldt E
    J Neurol Neurosurg Psychiatry; 1998 Jan; 64(1):78-83. PubMed ID: 9436732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epidemiology of myasthenia gravis in central and western Virginia.
    Phillips LH; Torner JC; Anderson MS; Cox GM
    Neurology; 1992 Oct; 42(10):1888-93. PubMed ID: 1407568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of Myasthenia Gravis in Slovakia in the Years 1977-2015.
    Martinka I; Fulova M; Spalekova M; Spalek P
    Neuroepidemiology; 2018; 50(3-4):153-159. PubMed ID: 29558746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and characteristics of Myasthenia gravis in Dar Es Salaam, Tanzania.
    Matuja WB; Aris EA; Gabone J; Mgaya EM
    East Afr Med J; 2001 Sep; 78(9):473-6. PubMed ID: 11921580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of myasthenia gravis in Denmark. A longitudinal and comprehensive population survey.
    Somnier FE; Keiding N; Paulson OB
    Arch Neurol; 1991 Jul; 48(7):733-9. PubMed ID: 1859301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A population based epidemiological study on myasthenia gravis in Estonia.
    Oöpik M; Kaasik AE; Jakobsen J
    J Neurol Neurosurg Psychiatry; 2003 Dec; 74(12):1638-43. PubMed ID: 14638881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Geographical distribution of a seropositive myasthenia gravis population.
    Heldal AT; Eide GE; Gilhus NE; Romi F
    Muscle Nerve; 2012 Jun; 45(6):815-9. PubMed ID: 22581533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of seropositive myasthenia gravis in Greece.
    Poulas K; Tsibri E; Kokla A; Papanastasiou D; Tsouloufis T; Marinou M; Tsantili P; Papapetropoulos T; Tzartos SJ
    J Neurol Neurosurg Psychiatry; 2001 Sep; 71(3):352-6. PubMed ID: 11511710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of myasthenia gravis.
    Kurtzke JF
    Adv Neurol; 1978; 19():545-66. PubMed ID: 369334
    [No Abstract]   [Full Text] [Related]  

  • 14. Epidemiology of myasthenia gravis in Ontario, Canada.
    Breiner A; Widdifield J; Katzberg HD; Barnett C; Bril V; Tu K
    Neuromuscul Disord; 2016 Jan; 26(1):41-6. PubMed ID: 26573434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and prevalence of myasthenia gravis in western Denmark: 1975 to 1989.
    Christensen PB; Jensen TS; Tsiropoulos I; Sørensen T; Kjaer M; Højer-Pedersen E; Rasmussen MJ; Lehfeldt E; de Fine Olivarius B
    Neurology; 1993 Sep; 43(9):1779-83. PubMed ID: 8414031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myasthenia gravis incidence in a general North Atlantic isolated population.
    Joensen P
    Acta Neurol Scand; 2014 Oct; 130(4):222-8. PubMed ID: 24981565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nationwide population-based epidemiological study of myasthenia gravis in taiwan.
    Lai CH; Tseng HF
    Neuroepidemiology; 2010; 35(1):66-71. PubMed ID: 20523074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of myasthenia gravis in Finland.
    Hokkanen E
    J Neurol Sci; 1969; 9(3):463-78. PubMed ID: 5367040
    [No Abstract]   [Full Text] [Related]  

  • 19. Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries.
    Andersen JB; Heldal AT; Engeland A; Gilhus NE
    Acta Neurol Scand Suppl; 2014; (198):26-31. PubMed ID: 24588503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of myasthenia gravis with anti-muscle specific kinase antibodies in The Netherlands.
    Niks EH; Kuks JB; Verschuuren JJ
    J Neurol Neurosurg Psychiatry; 2007 Apr; 78(4):417-8. PubMed ID: 17056627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.